DC

Decheng Capital Portfolio holdings

AUM $743M
1-Year Est. Return 136.97%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+136.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$743M
AUM Growth
+$170M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
23
New
Increased
Reduced
Closed

Top Buys

1
+$2.16M

Top Sells

1
+$17.6M
2
+$3.54M
3
+$3.16M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$2.37M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$2.24M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$4.86B
$265M 35.59%
6,371,669
NUVB icon
2
Nuvation Bio
NUVB
$2.03B
$233M 31.28%
25,954,439
UPB
3
Upstream Bio Inc
UPB
$415M
$85.3M 11.48%
3,143,078
-142,215
AARD
4
Aardvark Therapeutics
AARD
$272M
$51.4M 6.92%
3,917,299
LYEL icon
5
Lyell Immunopharma
LYEL
$510M
$21.3M 2.87%
692,050
+96,584
NAMS icon
6
NewAmsterdam Pharma
NAMS
$4.08B
$20.8M 2.79%
592,057
-64,994
RVMD icon
7
Revolution Medicines
RVMD
$19.7B
$15.9M 2.14%
200,000
-10,000
RCUS icon
8
Arcus Biosciences
RCUS
$2.52B
$12.9M 1.74%
541,559
-6,050
ACRS icon
9
Aclaris Therapeutics
ACRS
$311M
$12.2M 1.64%
4,041,736
EQ icon
10
Equillium
EQ
$111M
$6.89M 0.93%
4,447,308
BYSI icon
11
BeyondSpring
BYSI
$55.5M
$6.2M 0.83%
3,800,702
-485,402
CRNX icon
12
Crinetics Pharmaceuticals
CRNX
$4.21B
$4.32M 0.58%
92,700
-50,300
KRYS icon
13
Krystal Biotech
KRYS
$8.06B
$4.27M 0.57%
17,300
-15,000
AURA icon
14
Aura Biosciences
AURA
$374M
$1.96M 0.26%
360,483
-155,072
ZNTL icon
15
Zentalis Pharmaceuticals
ZNTL
$155M
$1.79M 0.24%
1,323,327
PYXS icon
16
Pyxis Oncology
PYXS
$91.5M
$376K 0.05%
326,810
FDMT icon
17
4D Molecular Therapeutics
FDMT
$493M
$332K 0.04%
44,311
-48,437
NUVB.WS
18
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$213K 0.03%
646,057
RZLT icon
19
Rezolute
RZLT
$307M
$141K 0.02%
59,900
ILMN icon
20
Illumina
ILMN
$20.6B
– –
-7,979
MLTX icon
21
MoonLake Immunotherapeutics
MLTX
$1.24B
– –
-181,600
MRUS
22
DELISTED
Merus
MRUS
– –
-186,546
GRAL
23
GRAIL Inc
GRAL
$2.08B
– –
-9,684